Replies to post #282 on Fate Therapeutics Inc (FATE)

[NY1972]

Why endometrial cancer? High TIL + high NK?
Two PRs (pending confirmation) were observed in patients with endometrial cancer, one whose cancer had progressed on prior checkpoint inhibitor therapy

[NY1972]

Why NKTX is not targeting cervical cancer?

NKTX could start by testing NKX101 in HCC, intrahepatic cholangiocarcinoma, and/or surgically resected CRC where only liver metastases remain via locoregional delivery.

[NY1972]

GMO is no match to organic NK.
Not counting CART relapsed saved by CD13 +CBNK, AB 101 +CD20 also saved
3 of 4 pts who failed prior CAR-T therapy.